H.R. 2063 · 115th Congress
Opioid PACE Act of 2017
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
SchneiderSponsor13 cosponsors · 13 D
D
Cicilline
RG
D
Gallego
TL
D
Lieu
JN
D
Nadler
MQ
D
Quigley
JS
D
Schakowsky
NV
D
Velázquez
TD
D
Deutch
EB
D
Blumenauer
DK
D
Kilmer
SM
D
Maloney
AS
D
Smith
RK
D
Khanna0 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Opioid Preventing Abuse through Continuing Education Act of 2017 or the Opioid PACE Act of 2017
What it does: CRS summary · Introduced in House · Apr 6, 2017
Opioid Preventing Abuse through Continuing Education Act of 2017 or the Opioid PACE Act of 2017
This bill amends the Controlled Substances Act to require a practitioner (other than a hospital, pharmacy, pharmacist, or veterinarian) to comply with a training requirement, as a condition of obtaining or renewing a registration to prescribe or dispense opioids for the treatment of pain or pain management.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Opioid PACE Act of 2017
Also known as: Opioid Preventing Abuse through Continuing Education Act of 2017
Latest action (May 1, 2017): Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Policy area: Health · Origin: House · Introduced: Apr 6, 2017
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.